Voluntary pause of the Phase 3 HERO and OLE trials evaluating ARD-101 for the treatment of hyperphagia in individuals with Prader-Willi Syndrome, further guidance on the program expected in Q2 2026 ...
Expect to submit an Investigational New Drug application for SZN-8141 to FDA in the second half of 2026 Scheduled to present retinal vascular research on SZN-8141 at the upcoming 2026 ARVO Annual ...
For example, parking and concessions revenue — smaller than you might think, since UConn doesn't own or operate the venues ...
PHILADELPHIA, PA / ACCESS Newswire / March 19, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, and digital engagement, and ...
Increased ARR Leads to Higher Gross Margins and Adjusted EBITDAQ4 2025 revenue grew modestly to $5.8M compared to $5.7M ...
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging ...
Navan (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today launched Expense Chat, a new AI agent designed to eliminate manual out-of-pocket expense submissions. The agent ...
We know that Sunday night at "WrestleMania 42" will be headlined by CM Punk defending his heavyweight title against Roman Reigns. The WWE is already calling it one of the biggest main events of all ...
NEW YORK — New York’s prison population is aging, leading to increased costs, according to a new report from the New York Comptroller. The report revealed that even as the prison population decreased ...
JPMorgan Chase (JPM) will host a company update event Monday evening, where its CEO Jamie Dimon is expected to make the case for spending $2B a week to drive the bank's future growth, the Financial ...
There have been two title fights in the UFC so far this year. And now, fans can expect to see another one at UFC 327. The event is scheduled for April 11 at the Kaseya Center in Miami, and details ...